The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Characterization of the 3xTg-AD mouse model of Alzheimer’s disease: Part 2. Behavioral and cognitive changes
Abstract
Alzheimer's disease (AD) is characterized by distinct behavioral and cognitive deficits that differ from those observed in normal aging. Transgenic models of AD are a promising tool in understanding the underlying mechanisms and cause of disease. The triple-transgenic mouse model of AD (3xTg-AD) is the only model to exhibit both Abeta and tau pathology that is characteristic of the human form. The present study characterized the performance of 3xTg-AD mice on several tasks measuring behavioral and cognitive ability. Aged 3xTg-AD females exhibited a higher level of fear and anxiety demonstrated by increased restlessness, startle responses, and freezing behaviors. No differences were observed in muscle strength and visuo-motor coordination. Understanding the behavioral manifestations that occur in this model of AD may aid in the early diagnosis and appropriate treatment of AD symptomology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Here Aβ deposition has not altered hippocampal functioning and the animals do not display long term memory alterations (Sterniczuk et al., 2010).”
From Early stage alterations in white matter and decreased functional interhemispheric hippocampal connectivity in the 3xTg mouse model of Alzheimer’s disease. (2019) · cites this paper as Sterniczuk et al., 2010
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citationThe open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037/0033-2909.83.3.482 · Cited by 2,389
Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Self-citationAttention and executive deficits in Alzheimer's disease: A critical review
Perry, R. J. (1999) · Brain · doi:10.1093/brain/122.3.383 · Cited by 1,252
Irwin, S. (1968) · Psychopharmacology · doi:10.1007/bf00401402 · Cited by 1,240
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
Delacourte, A., David, J. P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999) · Neurology · doi:10.1212/wnl.52.6.1158 · Cited by 828
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease
Witting, W., Kwa, I. H., Eikelenboom, P., Mirmiran, M., & Swaab, D. F. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90523-5 · Cited by 621
Estrogen Replacement Therapy in Older Women
Henderson, V. W. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210068014 · Cited by 590
Flagged first, then by citations
Cited by
Sorted by citations
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865
Sabogal-Guáqueta, A. M., Muñoz‐Manco, J. I., Ramírez‐Pineda, J. R., Lamprea, M. R., Osorio, E., & Cardona‐Gómez, G. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.027 · Cited by 453
Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363
Chen, Y., Liang, Z., Blanchard, J., Dai, C., Sun, S., Lee, M. H., Grundke, I., Iqbal, K., Liu, F., & Gong, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8375-5 · Cited by 294
Superoxide Dismutase Administration: A Review of Proposed Human Uses
Rosa, A. C., Corsi, D., Cavi, N., Bruni, N., & Dosio, F. (2021) · Molecules · doi:10.3390/molecules26071844 · Cited by 297
Metadata
- Authors
- Sterniczuk, R., Antle, M. C., LaFerla, F. M., & Dyck, R. H.
- Affiliations
- University of Calgary (CA)
- University of California, Irvine (US)
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 1348
- Pages
- 149-155
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1967375871
- Cited by
- 228
- References
- 43
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 14 · 2023: 17 · 2022: 18 · 2021: 24 · 2020: 20 · 2019: 13 · 2018: 10 · 2017: 12 · 2016: 11 · 2015: 16 · 2014: 19 · 2013: 12 · 2012: 12
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- NSERC
- CIHR
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- Alzheimer's disease, 3xTg-AD mice, triple transgenic mice, amyloid-beta pathology, tau pathology, cognitive impairment, behavioral deficits, anxiety, fear, startle response, freezing behavior, visuomotor coordination, muscle strength, aging
- MeSH terms
- Alzheimer Disease, Animals, Avoidance Learning, Behavioral Symptoms, Cognition Disorders, Disease Models, Animal, Exploratory Behavior, Female, Humans, Male, Mice, Inbred C57BL, Motor Activity, Neurologic Examination, Psychomotor Performance, Reaction Time, Time Factors, Amyloid beta-Protein Precursor, Statistics, Nonparametric, Maze Learning, Animals, Genetically Modified, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
